Next-generation antibody therapies, such as bispecific antibodies, nanobodies, and antibody-drug conjugates, promise to provide new solutions for infectious diseases, autoimmune disorders, cancer, and beyond. As scientists push the limits of antibody therapeutics, they require rapid, automated workflows for screening, isolating, and assaying antibody-secreting cells. New technology allows researchers to assay thousands of single primary antibody-secreting cells in just one day.
Download this ebook from Satorius to learn about
- New prospects for monoclonal antibody therapies
- Traditional and modern methods for antibody isolation
- Rapid primary B cell analysis with the CellCelector Flex automated platform
